Left Ventricular Noncompaction: Anatomical Phenotype or Distinct Cardiomyopathy?

Jonathan R Weir-McCall1, Phey Ming Yeap1, Carla Papagiorcopulo1

  • 1Department of Cardiovascular and Diabetes Medicine, College of Medicine, University of Dundee, Dundee, United Kingdom.

Insights

Left ventricular noncompaction (LVNC) criteria are met by a significant portion of healthy individuals, questioning if LVNC is a distinct disease or an anatomical variation. This study highlights poor specificity in current diagnostic methods for LVNC.

Area of Science:

  • Cardiology
  • Medical Imaging
  • Pathology

Background:

  • Left ventricular noncompaction (LVNC) shows significant overlap with other cardiomyopathies.
  • Its high prevalence in the general population (up to 40%) challenges its classification as a distinct pathological entity.
  • Questions arise whether LVNC is a pathological entity, a remodeling epiphenomenon, or an anatomical phenotype.

Purpose of the Study:

  • To determine the prevalence and predictors of LVNC in a healthy population.
  • To evaluate the diagnostic performance of four cardiac magnetic resonance imaging (CMR) criteria for LVNC.
  • To investigate the specificity of current LVNC diagnostic criteria in an asymptomatic cohort.

Main Methods:

  • 1,651 volunteers over 40 without cardiovascular disease (CVD) underwent CMR.
  • Four diagnostic criteria for LVNC were applied, including noncompaction ratios and myocardial mass ratios.
  • Participants meeting all four criteria were classified as having LVNC.

Main Results:

  • Of 1,480 analyzed participants, 1.3% met all four diagnostic criteria for LVNC.
  • 14.8% met at least one criterion, indicating low specificity of current diagnostic methods.
  • The noncompacted to compacted myocardial mass ratio was the most specific criterion (4.4%).

Conclusions:

  • A substantial proportion of asymptomatic individuals without CVD meet current CMR diagnostic criteria for LVNC.
  • This suggests that current criteria have poor specificity for diagnosing LVNC.
  • LVNC may represent an anatomical phenotype rather than a distinct cardiomyopathy.
Abstract

Related Concept Videos

Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
603
Cardiomyopathy I: Introduction and Classification01:25

Cardiomyopathy I: Introduction and Classification

Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...
743
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
698
Cardiomyopathy IV: Restrictive Cardiomyopathy01:29

Cardiomyopathy IV: Restrictive Cardiomyopathy

Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
706
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
566
Imbalances in Cardiac Output01:26

Imbalances in Cardiac Output

The heart's primary function is to pump blood throughout the body, maintaining a balance between blood sent out (cardiac output) and blood returning (venous return). If this balance is disrupted, it can result in congestive heart failure (CHF), a severe condition where the heart becomes an inefficient pump, leading to inadequate blood circulation.
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send...
3.4K